
DCVC Announcements
Shennon has built an ultra-high-throughput profiling engine that allows it to analyze millions of immune cells on the single-cell level, searching for rare receptors and other targets that will help the company create more effective immunotherapies for solid tumors.
Programming stem cells to differentiate into desired cell types, faster
Using state-of-the-art machine learning models to create custom-build protein drugs
Mapping the brain-body axis to achieve proper immune balance
Using AI to speed through the last mile of drug discovery